Akathisia Stories, a co-production of MISSD and Studio C, is a podcast series that features interviews and news concerning the adverse drug reaction akathisia and medication-induced suicide.
MISSD, the Medication-Induced Suicide Prevention and Education Foundation in Memory of Stewart Dolin, is a unique non-profit organization dedicated to honouring the memory of Stewart and other victims of akathisia by raising awareness and educating the public about the dangers of akathisia. MISSD aims to ensure that people suffering from akathisia's symptoms are accurately diagnosed so that needless deaths are prevented. The foundation advocates truth in disclosure, honesty in reporting, and legitimate drug trials.
On this episode, we hear from author, blogger, researcher, and self-described humanist and humourist Bob Fiddaman. His eponymously titled blog has focused on drug company and regulatory malfeasance since making its debut in 2006. At the time, Bob, an Englishman living in Birmingham, was taking himself off of Seroxat, a GlaxoSmithKline-produced antidepressant known here in America as Paxil. After making a protracted attempt at tapering off of the drug, he eventually decided to go cold turkey, a course of action he strongly advises against.
Full show here
Podcast extra here
Bob Fiddaman
No comments: